Literature DB >> 33927479

Propofol inhibits proliferation, migration, invasion and promotes apoptosis by regulating HOST2/JAK2/STAT3 signaling pathway in ovarian cancer cells.

Xiang Shen1, Diaolan Wang1, Xu Chen2, Jun Peng1.   

Abstract

We aimed to investigate the effect of propofol on the growth of human ovarian cancer cells ES2 and OVCAR-3 in vitro by regulating long non-coding RNA HOST2 (human ovarian cancer-specific transcript 2) and the inhibition of JAK2/STAT3 signaling pathway. In the present study, ES-2 and OVCAR-3 cells were firstly treated with different concentrations of propofol (0, 1, 5 and 10 μg/ml). The expression of HOST2 in ES-2 and OVCAR-3 cells were detected by quantitative reverse transcription-PCR (qRT-PCR). Then, the expression of HOST2 was changed by transfection of HOST2 overexpression plasmid into ES-2 and OVCAR-3 cells. Cell proliferation, migration, invasion and apoptosis were performed using CCK-8, wound-healing, Transwell assays and Flow Cytometry. Western blot analysis was performed to detect the expressions of apoptosis-associated proteins and JAK2/STAT3 pathway-related proteins. Results showed that cell viability and intracellular HOST2 expression in ES-2 and OVCAR-3 cells were decreased gradually with the increase of propofol concentration in a dose-dependent manner. Compared with the propofol group, overexpression of HOST2 significantly promoted the cell proliferation, migration, invasion and inhibited apoptosis, and ameliorated the inhibitory effect of propofol on the growth of tumor cells. Western blot analysis showed that compared with propofol group, the expression of Bcl-2 was significantly increased whereas Bax and the ratio of Cleaved caspase3/caspase3 were significantly decreased in pcDNA-HOST2 group. In addition, overexpression of HOST2 significantly enhanced the phosphorylation level of JAK2 and STAT3, and reduced the suppressive effect of propofol on JAK2/STAT3 signaling. Our results illustrated that propofol could significantly inhibit the proliferation, migration, invasion and induce apoptosis of ES-2 and OVCAR-3 cells by downregulating HOST2. The regulation mechanism may be achieved by inhibiting the activation of JAK2/STAT3 signaling pathway.
© The Author(s), under exclusive licence to Springer Nature B.V. 2021.

Entities:  

Keywords:  Apoptosis; HOST2; JAK2/STAT3; Ovarian cancer; Proliferation; Propofol

Year:  2021        PMID: 33927479      PMCID: PMC8035385          DOI: 10.1007/s10616-021-00462-7

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  31 in total

1.  CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis.

Authors:  Gong Yang; Daniel G Rosen; Guangzhi Liu; Fan Yang; Xiaoqing Guo; Xue Xiao; Fengxia Xue; Imelda Mercado-Uribe; Jiaoti Huang; Sue-Hwa Lin; Gordon B Mills; Jinsong Liu
Journal:  Clin Cancer Res       Date:  2010-05-26       Impact factor: 12.531

2.  Correlation Between Pelvic Peritoneal Disease and Nodal Metastasis in Advanced Ovarian Cancer: Can Intraoperative Findings Define the Need for Systematic Nodal Dissection?

Authors:  Praveen Kammar; Aditi Bhatt; Jay Anam; Shazia Waghoo; Jageshwar Pandey; Sanket Mehta
Journal:  Indian J Surg Oncol       Date:  2019-02-07

3.  Propofol induces apoptosis of epithelial ovarian cancer cells by upregulation of microRNA let-7i expression.

Authors:  Z Su; X K Hou; Q P Wen
Journal:  Eur J Gynaecol Oncol       Date:  2014       Impact factor: 0.196

4.  Butein suppresses constitutive and inducible signal transducer and activator of transcription (STAT) 3 activation and STAT3-regulated gene products through the induction of a protein tyrosine phosphatase SHP-1.

Authors:  Manoj K Pandey; Bokyung Sung; Kwang Seok Ahn; Bharat B Aggarwal
Journal:  Mol Pharmacol       Date:  2008-12-22       Impact factor: 4.436

Review 5.  Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes.

Authors:  Manish K Tripathi; Kyle Doxtater; Fatemeh Keramatnia; Chidi Zacheaus; Murali M Yallapu; Meena Jaggi; Subhash C Chauhan
Journal:  Drug Discov Today       Date:  2018-04-23       Impact factor: 7.851

6.  HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer.

Authors:  K Kim; I Jutooru; G Chadalapaka; G Johnson; J Frank; R Burghardt; S Kim; S Safe
Journal:  Oncogene       Date:  2012-05-21       Impact factor: 9.867

Review 7.  Sedation methods for intra-articular corticosteroid injections in Juvenile Idiopathic Arthritis: a review.

Authors:  Amit Oren-Ziv; David Hoppenstein; Ayelet Shles; Yosef Uziel
Journal:  Pediatr Rheumatol Online J       Date:  2015-07-04       Impact factor: 3.054

8.  Characterization of long non-coding RNA-associated ceRNA network to reveal potential prognostic lncRNA biomarkers in human ovarian cancer.

Authors:  Meng Zhou; Xiaojun Wang; Hongbo Shi; Liang Cheng; Zhenzhen Wang; Hengqiang Zhao; Lei Yang; Jie Sun
Journal:  Oncotarget       Date:  2016-03-15

9.  Propofol Suppresses Esophageal Squamous Cell Carcinoma Cell Migration and Invasion by Down-Regulation of Sex-Determining Region Y-box 4 (SOX4).

Authors:  Chun-Li Zhou; Jing-Jing Li; Peng Ji
Journal:  Med Sci Monit       Date:  2017-01-24

10.  Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas.

Authors:  M Colomiere; A C Ward; C Riley; M K Trenerry; D Cameron-Smith; J Findlay; L Ackland; N Ahmed
Journal:  Br J Cancer       Date:  2008-12-16       Impact factor: 7.640

View more
  1 in total

1.  Propofol Augments Paclitaxel-Induced Cervical Cancer Cell Ferroptosis In Vitro.

Authors:  Meng-Yun Zhao; Pan Liu; Chen Sun; Li-Jian Pei; Yu-Guang Huang
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.